Status:
COMPLETED
Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status
Lead Sponsor:
Guangfu Dang
Conditions:
Primary Angle Closure Glaucoma
Eligibility:
All Genders
47-91 years
Brief Summary
The goal of this observational study is to discuss the correlation between primary angle-closure glaucoma and the state of the suspended ligament of the lens and the pathogenesis of PACG by measuring ...
Detailed Description
Patients clinically diagnosed with Primary angle-closure glaucoma (PACG) and normal control patients from December 2020 to January 2022 were enrolled in this study.
Eligibility Criteria
Inclusion
- The depth of the anterior chamber is normal, and the whole corner of the chamber is open;
- The cup-to-plate ratio is less than 0.5;
- No family history of glaucoma.
Exclusion
- Previous history of trauma or internal eye surgery in both eyes or one eye;
- Used "pilocarpine", "atropine" and other drugs to change the size of the pupil and the shape of the chamber Angle within 1 week;
- Combined with other eye diseases affecting the Angle and suspension ligament, such as uveitis, ciliary cyst, high myopia, retinal diseases, etc.;
- Can not cooperate with UBM and Angle scopy;
- Refuse to participate in this researcher.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
263 Patients enrolled
Trial Details
Trial ID
NCT06184620
Start Date
December 1 2020
End Date
March 30 2023
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
guangfu Dang
Jinan, Shandong, China, 250000